People · Operator
Named in public records as an officer, director or promoter · active 2019–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vivos BioTechnologies, Inc. | — | Biotechnology | Seed | $3.6M | $24.7M | 2019 |
Paul J. Lajoie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Paul J. Lajoie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kelly J. McCrann | 1 | 2 |
| Gurdev Dave Singh | 1 | 2 |
| Gregg C.E. Johnson | 1 | 2 |
| Bradford Dave Amman | 1 | 1 |
| R. Kirk Huntsman | 1 | 1 |
| Edward L. Loew | 1 | 1 |
| Terrence L. Hales | 1 | 1 |
| Thomas P. Madden | 1 | 1 |
| Will L. Meris | 1 | 1 |
| Dan J. McKeon | 1 | 1 |
| Cody Dave Teets | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.